The Biopharma Pod William Reed Business Media

In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.

Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.

A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.